Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02069522 · ClinicalTrials.gov registry record · NA
Healthy Term Infants Fed Milk-Based Formulas
A NA study, sponsored by Abbott Nutrition.
- Terminated
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT02069522: Clinical Trial NA study, sponsored by Abbott Nutrition.
NCT02069522 is a NA study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02069522, a NA study, was terminated before completion, sponsored by Abbott Nutrition.
- TERMINATED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
This is a prospective, double blind, crossover study in healthy infants randomized to one of two study formulas. The trial will consist of two 21 day study feeding periods separated by a study washout period.
Primary Outcome
Plasma sample
Interventions
- OTHER Standard Milk-based Formula Containing Carotenoid
- OTHER Investigational Milk-based Formula Containing Carotenoid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-02 |
| Phase | NA |
Why NCT02069522 stopped before completion
NCT02069522 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Milk-based Formula Containing Carotenoid is the first listed.
NCT02069522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02069522 about?
NCT02069522 is a clinical study titled "Healthy Term Infants Fed Milk-Based Formulas". This is a prospective, double blind, crossover study in healthy infants randomized to one of two study formulas. The trial will consist of two 21 day study feeding periods separated by a study washout period.
What is the current status of trial NCT02069522?
This trial is currently terminated. It is a NA study. The enrollment target is 91 participants. The study started on 2014-02. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02069522?
The interventions under investigation include: Standard Milk-based Formula Containing Carotenoid (OTHER), Investigational Milk-based Formula Containing Carotenoid (OTHER).
Who is sponsoring clinical trial NCT02069522?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02069522's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia